These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
242 related items for PubMed ID: 28285962
1. The ERK/MAPK pathway is overexpressed and activated in gallbladder cancer. Buchegger K, Silva R, López J, Ili C, Araya JC, Leal P, Brebi P, Riquelme I, Roa JC. Pathol Res Pract; 2017 May; 213(5):476-482. PubMed ID: 28285962 [Abstract] [Full Text] [Related]
2. Prohibitin overexpression predicts poor prognosis and promotes cell proliferation and invasion through ERK pathway activation in gallbladder cancer. Cao Y, Liang H, Zhang F, Luan Z, Zhao S, Wang XA, Liu S, Bao R, Shu Y, Ma Q, Zhu J, Liu Y. J Exp Clin Cancer Res; 2016 Apr 16; 35():68. PubMed ID: 27084680 [Abstract] [Full Text] [Related]
9. Fibronectin promotes cell proliferation and invasion through mTOR signaling pathway activation in gallbladder cancer. Cao Y, Liu X, Lu W, Chen Y, Wu X, Li M, Wang XA, Zhang F, Jiang L, Zhang Y, Hu Y, Xiang S, Shu Y, Bao R, Li H, Wu W, Weng H, Yen Y, Liu Y. Cancer Lett; 2015 May 01; 360(2):141-50. PubMed ID: 25657110 [Abstract] [Full Text] [Related]
12. PLEK2 promotes gallbladder cancer invasion and metastasis through EGFR/CCL2 pathway. Shen H, He M, Lin R, Zhan M, Xu S, Huang X, Xu C, Chen W, Yao Y, Mohan M, Wang J. J Exp Clin Cancer Res; 2019 Jun 10; 38(1):247. PubMed ID: 31182136 [Abstract] [Full Text] [Related]
13. [Artemisinin inhibits proliferation of gallbladder cancer cell lines through triggering cell cycle arrest and apoptosis]. Jia JG, Zhang LG, Guo CX, Wang YG, Chen BL, Wang YM, Qian J. Zhonghua Wai Ke Za Zhi; 2016 Mar 01; 54(3):222-7. PubMed ID: 26932893 [Abstract] [Full Text] [Related]
14. Decreased expression of hsa‑miR‑372 predicts poor prognosis in patients with gallbladder cancer by affecting chloride intracellular channel 1. Zhou N, Cheng W, Peng C, Liu Y, Jiang B. Mol Med Rep; 2017 Nov 01; 16(5):7848-7854. PubMed ID: 28944858 [Abstract] [Full Text] [Related]
15. Oxidative stress and deregulations in base excision repair pathway as contributors to gallbladder anomalies and carcinoma - a study involving North-East Indian population. Singh N, Kazim SN, Sultana R, Tiwari D, Borkotoky R, Kakati S, Nath Das N, Kumar Saikia A, Bose S. Free Radic Res; 2019 May 01; 53(5):473-485. PubMed ID: 31117842 [Abstract] [Full Text] [Related]
16. A potent therapeutics for gallbladder cancer by combinatorial inhibition of the MAPK and mTOR signaling networks. Mohri D, Ijichi H, Miyabayashi K, Takahashi R, Kudo Y, Sasaki T, Asaoka Y, Tanaka Y, Ikenoue T, Tateishi K, Tada M, Isayama H, Koike K. J Gastroenterol; 2016 Jul 01; 51(7):711-21. PubMed ID: 26614007 [Abstract] [Full Text] [Related]
17. [Expression of ERK1/2 MAPK signaling transduction pathway in esophageal cancers in Kazakh patients]. Zheng ST, Liu T, Middottuersun A, Huo Q, Liu Q, Huang CG, Feng JG, Lü GD, Wang X, Lin RY, Sheyhidin I, Lu XM. Zhonghua Zhong Liu Za Zhi; 2011 Jun 01; 33(6):421-5. PubMed ID: 21875481 [Abstract] [Full Text] [Related]
18. Estrogen-related receptor-α promotes gallbladder cancer development by enhancing the transcription of Nectin-4. Wang L, Yang M, Guo X, Yang Z, Liu S, Ji Y, Jin H. Cancer Sci; 2020 May 01; 111(5):1514-1527. PubMed ID: 32030850 [Abstract] [Full Text] [Related]
19. Inhibitory effects of deleted in liver cancer 1 gene on gallbladder cancer growth through induction of cell cycle arrest and apoptosis. Qin Y, Chu B, Gong W, Wang J, Tang Z, Shen J, Quan Z. J Gastroenterol Hepatol; 2014 May 01; 29(5):964-72. PubMed ID: 24329682 [Abstract] [Full Text] [Related]
20. Overexpressed microRNA-136 works as a cancer suppressor in gallbladder cancer through suppression of JNK signaling pathway via inhibition of MAP2K4. Niu J, Li Z, Li F. Am J Physiol Gastrointest Liver Physiol; 2019 Nov 01; 317(5):G670-G681. PubMed ID: 31369289 [Abstract] [Full Text] [Related] Page: [Next] [New Search]